NEW YORK, Nov. 19, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether AdaptHealth and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AdaptHealth Corp. – AHCO
Tag: Financial Results
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DermTech, Inc. – DMTK
NEW YORK, Nov. 19, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DermTech, Inc. (“DermTech” or the “Company”) (NASDAQ: DMTK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether DermTech and certain of its officers and/or directors have engaged in securities fraud or other unlawful… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DermTech, Inc. – DMTK
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. – SCYX
NEW YORK, Nov. 19, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SCYNEXIS, Inc. (“SCYNEXIS” or the “Company”) (NASDAQ: SCYX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether SCYNEXIS and certain of its officers and/or directors have engaged in securities fraud or other unlawful business… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. – SCYX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Airbnb, Inc. – ABNB
NEW YORK, Nov. 19, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Airbnb, Inc. (“Airbnb” or the “Company”) (NASDAQ: ABNB). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Airbnb and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Airbnb, Inc. – ABNB
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Medical Properties Trust, Inc. and Certain Officers of Class Action Lawsuit and Upcoming Deadline – MPW
NEW YORK, Nov. 19, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Medical Properties Trust, Inc. (“MPW” or the “Company”) (NYSE: MPW) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 23-cv-08597, is on… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Medical Properties Trust, Inc. and Certain Officers of Class Action Lawsuit and Upcoming Deadline – MPW
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acelyrin, Inc. of Class Action Lawsuit and Upcoming Deadline – SLRN
NEW YORK, Nov. 19, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Acelyrin, Inc. (“Acelyrin” or the “Company”) (NASDAQ: SLRN) and certain officers. The class action, filed in the United States District Court for the Central District of California, and docketed under 23-cv- 09672, is on behalf of… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acelyrin, Inc. of Class Action Lawsuit and Upcoming Deadline – SLRN
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Outlook Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – OTLK
NEW YORK, Nov. 19, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 23-cv-21862, is on behalf of… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Outlook Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – OTLK
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in DLocal Limited of Class Action Lawsuit and Upcoming Deadline – DLO
NEW YORK, Nov. 19, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against DLocal Limited (“DLocal” or the “Company”) (NASDAQ: DLO) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 23-cv-07501, is on behalf of… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in DLocal Limited of Class Action Lawsuit and Upcoming Deadline – DLO
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nikola Corporation of Class Action Lawsuit and Upcoming Deadline – NKLA
NEW YORK, Nov. 19, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Nikola Corporation (“Nikola” or the “Company”) (NASDAQ: NKLA) and certain officers. The class action, filed in the United States District Court for the District of Arizona, and docketed under 23-cv-02131, is on behalf of a class… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nikola Corporation of Class Action Lawsuit and Upcoming Deadline – NKLA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sweetgreen, Inc. – SG
NEW YORK, Nov. 19, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sweetgreen, Inc. (“Sweetgreen” or the “Bank”) (NYSE: SG). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Sweetgreen and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sweetgreen, Inc. – SG